ITSSD President Delivers Presentation at Moscow Entrepreneur's Association

As the result of the well-received article entitled How Market-Based Policies Could Spur Biotechnology Growth In Russia, recently co-authored by ITSSD President/CEO Lawrence Kogan and Russian government lawyer Yelena Bakulina, accessible at: http://www.wlf.org/upload/03-21-08balukina.pdf; http://www.insideronline.org/summary.cfm?id=7019; and http://www.itssd.org/Publications/03-21-08balukina.pdf , the ITSSD was invited to deliver a presentation at the 9th International Forum on High Technology of the 21st Century, convened by the Moscow Entrepreneur's Association and the U.S.-based Mid-Atlantic Russian Business Council on April 24, 2008.


Information about the event, which took place at the Moscow ExpoCenter, is accessible at: http://ma-rbc.org/event/9hightech.html .


The ITSSD powerpoint presentation is accessible at: http://www.itssd.org/Programs/KoganPresentationMidAtlanticRussiaBusinessCouncilMoscowExhibitionApril2008.ppt .

ITSSD President Participates in Moscow EurasiaBIO Conference Following Well-Received IP Tech Transfer Article

As the result of the well-received article entitled How Market-Based Policies Could Spur Biotechnology Growth In Russia, recently co-authored by ITSSD President/CEO Lawrence Kogan and Russian government lawyer Yelena Bakulina, accessible at: http://www.wlf.org/upload/03-21-08balukina.pdf; http://www.insideronline.org/summary.cfm?id=7019; and http://www.itssd.org/Publications/03-21-08balukina.pdf , the ITSSD was invited to participate in the First EurasiaBIO Congress Conference convened in Moscow, Russia during April 24-25, 2008.


A copy of the press release announcing the Kogan-Bakulina article appears on the EurasiaBIO website at: http://www.eurasiabio.org/; and http://www.eurasiabio.org/media/news/itssd_russia_can_secure_greatest_biotech_market_advances_following_us_not_eu_innovation_model/

The Official Program of the FIRST INTERNATIONAL CONGRESS FOR BIOTECHNOLOGY, BIOENERGY AND BIOECONOMY is accessible at: http://www.eurasiabio.ru/images/Program/Program/EAB%20V19eng%20FINAL-site.doc .


The ITSSD powerpoint presentation delivered at the EurasiaBIO event is accessible at:
http://www.itssd.org/Programs/KoganPresentationEurasiaBIOMoscowConferenceApril2008.ppt .



The EurasiaBIO Congress is the global event for Biotechnology and Renewable Energy in Russia and CIS countries. The Congress is hosted by the Yu.A. Ovchynnikov Russian Biologists Society and the Russian National Biofuel Asociation. The event offers an unparalleled opportunity for biotechnology, pharmaceutical and energy companies, academic research institutions, and investors from around the world to gather in one place at one time to learn about each other, meet one-on-one, and discuss business opportunities of mutual interest.


The EurasiaBIO is supported by:
The State Duma of the Russian Federation Ministry of Industry and Energetics of the Russian Federation Ministry of Agriculture of the Russian FederationRussian Academy of SciencesRussian Academy of Agricultural SciencesEuropean Federation of BiotechnologyEuropean Commission Research DG

Russian Duma Speaker Recognizes Need For Government Support of Small Inventors to Promote Market Advance of Sciences

http://www.eurasiabio.org/media/news/duma_speaker__gryzlov_advocates__the__state_support_of_inventors/

Duma speaker Gryzlov advocates the state support of inventors




RIA Nowosti


Дата: 28.03.2008




Duma speaker and the "United Russia" leader Boris Gryzlov believes that the state has to substantially increase the assistance of creative people , to enlarge the financing of research and construction ventures.


He pointed out that presently the financing of research and construction works in Russia totals 1% of the GNP while the correspondent figure in developed countries is 4-6 times higher.


The inventions presenting the frontier of the science demand substantial assets to be implemented and the inventors usually badly lack the money.

Russia Can Secure Greatest Biotech Market Advances Following US, Not EU Innovation Model

http://www.wlf.org/upload/03-21-08balukina.pdf

ITSSD: Russia Can Secure Greatest Biotech Market Advances Following US, Not EU Innovation Model

PRINCETON, N.J., March 21 /PRNewswire-USNewswire/ -- In a short article published today by the Washington Legal Foundation, US international trade and business lawyer Lawrence Kogan and Russian Government lawyer Yelena Bakulina highlight the common bases in Russian and US history that have triggered new thinking in Russia about how to use privately owned patent rights and cooperative government-university-industry technology transfer arrangements to secure successful market commercialization and peaceful adaptation of publicly-owned bio-warfare technologies.

The article arose from Kogan's June 28, 2007 presentation at a symposium convened by the Vyatka State University, Kirov, Russia, [http://www.vshu.kirov.ru/] as part of a longstanding joint Russian-US cooperative nonproliferation program overseen by the International Science and Technology Center (ISTC), Moscow, Russia. [http://www.istc.ru/]

According to Bakulina and Kogan, "The [US] federal government['s]...transference of innovation from energy, space, and defense to that of the private sector, and...the American experience in innovation and intellectual property may be advantageous to use in Russia..."

Furthermore as the authors note, "The Kirov Region certainly has the potential to develop effective innovation systems supported by the investment and protection of privately owned intellectual property in the sphere of modern high tech technology. If properly managed...this could create jobs, know-how and other economic and social benefits in the Kirov Region."


"Such an approach," adds Kogan, "would allow Russian biotechnology markets to leapfrog those of the European Union to capture a greater share of the global marketplace for biomedical and bioenvironmental products and processes. Unfortunately, the current EU innovation model is fixated on governmental market control via regulation rather than on market facilitation via economic incentives that ease the burdens and costs of doing business," emphasizes Kogan. "The EU Commission is more obsessed with dictating the rules of the game to ensure 'parity-over-progress' than with providing hi tech European businesses operating in the biotech sectors with
the necessary property rights-based enabling environment and economic freedom to grow and prosper. "Consequently," Kogan notes, "EU biotech and pharma companies have increasingly relocated operations to the US."


The Institute for Trade, Standards and Sustainable Development (ITSSD) is a non-partisan non-profit international legal research and educational organization that examines international law relating to trade, industry and positive sustainable development around the world. This and related ITSSD articles are accessible online at:
http://www.itssd.org/Publications/03-21-08balukina.pdf; http://www.itssd.org/ and http://itssdinternationaliprights.blogspot.com/.


CONTACT: ITSSD, +1-609-951-2222, info@itssd.org